Lercanidipine
- 1 November 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Heart Disease
- Vol. 3 (3) , 398-407
- https://doi.org/10.1097/00132580-200111000-00008
Abstract
Lercanidipine is a dihydropyridine calcium channel antagonist used for treatment of hypertension …Keywords
This publication has 62 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?Journal of Human Hypertension, 1997
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Prevalence of Hypertension in the US Adult PopulationHypertension, 1995
- Blood Pressure, Systolic and Diastolic, and Cardiovascular RisksArchives of internal medicine (1960), 1993